As of January 22, 2025, Vir Biotechnology (VIR) has a market cap of $1.45 billion USD. According to our data, Vir Biotechnology is ranked No.4646 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.45 B |
43.46%
|
Dec 31, 2024 | $1.01 B |
-27.04%
|
Dec 29, 2023 | $1.39 B |
-60.25%
|
Dec 30, 2022 | $3.49 B |
-39.55%
|
Dec 31, 2021 | $5.77 B |
56.35%
|
Dec 31, 2020 | $3.69 B |
112.96%
|
Dec 31, 2019 | $1.73 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Market Cap | = | VIR Stock Price | * | VIR Shares Outstanding |
= | $10.53 | * | 0.14 B | |
= | $1.45 B |